3340 results for «2021»

Filter By

3340 results

Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

17 Sep 2022

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials

COVID-19: safety and efficacy of the mRNA-1273 SARSCoV-2 vaccine (Moderna) against SARS-CoV-2

22 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the Moderna vaccine

Simultaneous aortography and left ventriculography for transcatheter valve-in-valve implantation in patients with a stentless bioprosthetic aortic valve

16 Dec 2022

Thanks to this image in cardiology, watch how an 82-year-old female patient underwent transcatheter ViV implantation for symptomatic severe SVD of the stentless pericardial bioprosthesis that had been implanted 4 years ago.

SAL technique for stentless bioprosthetic valves

Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial

09 Nov 2022

Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.

Alessandro Sticchi

Author

Alessandro Sticchi
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected coronary artery disease: the PRECISE randomized trial

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

03 Nov 2023

Fire Trial Shows Positive Results, presented at ESC Congress 2023

29 Aug 2023

FIRE1 raises $25M to revolutionize heart failure home monitoring

15 Mar 2023

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

21 May 2025

Simplified dual-indeflator approach for bioprosthetic valve fracture

02 Sep 2024

The standard BVF procedure involves multiple quick maneuvers. Simplifying the setup, minimizing operator actions, and shortening rapid pacing could reduce associated risks. Find out how!

Karim Ratib

Author

Karim Ratib
Dr. Andrija Matetic

Author

Andrija Matetic
Khaled Elsayed

Author

Khaled Elsayed
Simplified dual-indeflator approach for bioprosthetic valve fracture

Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

31 Oct 2025

Nicola Ryan provides her take on the PROMISE trial presented by Rocco Antonio Montone at TCT 2025, in San Francisco.

Nicola Ryan

Author

Nicola Ryan
Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult

04 Nov 2021

View this case with a 38-year-old male with effort angina and chronic total occlusion at the ostial segment of the left anterior descending artery.

Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

05 Apr 2022

This Image in Interventional Cardiology highlights how patient-specific ex vivo simulations offer physicians the opportunity to observe and evaluate the potential in vivo impact of different techniques particularly for complex structural heart interventions.

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

12 Jan 2022

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

28 Jan 2022

Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

28 Jan 2022

News regarding the SIRONA Randomized Trial

10 Feb 2022

GENESIS-II study reveals promising 30-day results for the hydra self-expanding transcatheter aortic valve

16 May 2024

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

COVID-19 vaccines: Burning questions from the community and real-world applicability
Didn’t find what you were looking for?